The Therapeutic Goods Administration says the benefits of the AstraZeneca vaccine far outweigh the risks after a NSW woman died from a blood clot in the brain.
The TGA says the 52-year-old who died was among four new clotting cases linked to the vaccine.
The other three involved a 77-year-old man from NSW, a 70-year-old man from South Australia, and an 87-year-old South Australian woman.
There are also four other cases with a “probable” link to the AstraZeneca vaccine, the TGA said. They are a woman, 50, and two men, aged 83 and 91, all from NSW, and a woman,